ライフサイエンスコーパス: deferens

1 at the junction of the epididymis and ductus deferens.

2 rve terminals in the guinea-pig isolated vas deferens.

3 tate, coagulating gland, epididymis, and vas deferens.

4 bule and collected by cannulation of the vas deferens.

5 e lungs, pancreas, liver, intestine, and vas deferens.

6 in precapillary arterioles in ureter and vas deferens.

7 inje cell bodies and cells lining the ductus deferens.

8 icle, bulbourethral gland, and caudal ductus deferens.

9 greater in femoral artery as compared to vas deferens.

10 lular CPI-17 concentration of the phasic vas deferens.

11 smission has a physiological role in the was deferens.

12 rescence in the tunica muscularis of the vas deferens.

13 e to congenital bilateral absence of the vas deferens.

14 edominantly to the cell periphery in the vas deferens.

15 an immotile state in the epididymis and vas deferens (2,4-6).

16 rtility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffect

17 stines, lungs, pancreas, sweat ducts and vas deferens, among others.

18 As a result, the epididymis, vas deferens and efferent ductules were largely absent in mu

19 oth muscle preparation of the guinea-pig vas deferens and from isolated bovine adrenal chromaffin cel

20 ompounds described in the isolated mouse vas deferens and guinea pig ileum bioassays revealed that al

21 Evaluation of the ligands in the mouse vas deferens and guinea pig ileum preparations revealed that

22 al assays (electrically stimulated mouse vas deferens and guinea pig ileum).

23 ermined from functional assays in rabbit vas deferens and inhibition constant (Ki) of 0.02 nM measure

24 n of Wolffian ducts into the epididymis, vas deferens and seminal vesicle.

25 ormal P2X1 receptor functionality in the vas deferens and that its absence leads to impaired peristal

26 Fluorogold into the junction between the vas deferens and the cauda labeled a population of neurons i

27 In the vas deferens and the ileal submucosa, P2X1 immunoreactivity

28 ract, including the seminal vesicle, the vas deferens and the prostate.

29 mal escape reflex, mispositioning of the vas deferens and uterus, and mitotic chromosome loss and mul

30 ity toward delta-opioid receptors (mouse vas deferens) and produced analgesia in mice in a naloxone r

31 ype, congenital bilateral absence of the vas deferens, and determined whether mutant CFTR could regul

32 hidism and abnormal tortuosity of the ductus deferens, and female transheterozygotes exhibited abnorm

33 cific structures such as the epididymis, vas deferens, and seminal vesicle from a straight Wolffian d

34 cells of: lung, oviduct, epididymis, ductus deferens, and seminiferous tubules.

35 at similar cells are also present in the vas deferens, and that a bafilomycin-sensitive proton flux c

36 rincipal cells of the epididymis and the vas deferens, and that both NHERF1 and CFTR co-immunoprecipi

37 rus anteriorized towards oviduct and the vas deferens anteriorized towards epididymis.

38 ive alpha1A-ARs from rat tail artery and vas deferens are also desensitized by OXY, but not by NE or

39 guinea pig ileum assay) and delta (mouse vas deferens assay) opioid receptors, respectively.

40 ide chain exchange was seen in the mouse vas deferens assay.

41 e3 was required for bioactivity in mouse vas deferens but not for interaction with delta opioid recep

42 ffian duct and formed the epididymis and vas deferens, but failed to elaborate the efferent ductules,

43 in single cells from the Syrian hamster vas deferens cell line DDT1MF-2 were investigated using the

44 detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and salivar

45 epinephrine release studies performed in vas deferens confirmed these findings.

46 Clear cells of the epididymis and vas deferens contain abundant V-ATPase in their apical pole

47 The maximal inhibition of vas deferens contraction by the alpha2 agonist in alpha2A-AR

48 or and sperm counts, but abnormal distal vas deferens convolution resulting in complete and incomplet

49 Treatment of hamster ductus deferens (DDT1MF-2) cells and porcine aortic smooth musc

50 with electrical field stimulation (EFS; vas deferens), dimethylphenylpiperazinium (chromaffin cells)

51 onium ileus (MI); pancreatic, liver, and vas deferens disease; and a predisposition to lung infection

52 In vitro, Entpd1(-/-) vas deferens displayed an exacerbated contraction to ATP, a

53 lly mediated sperm transport through the vas deferens during the emission phase of ejaculation.

54 0.4 million for Entpd1(+/+)) pointed to vas deferens dysfunction.

55 structing cysts of the seminal vesicles, vas deferens, ejaculatory ducts, or prostate in 26 (9.4%) pa

56 effects of the polypropylene mesh on the vas deferens, especially with regard to fertility.

57 le response to electrical stimulation in vas deferens from alpha2B-AR knockout, alpha2C-AR knockout,

58 ) in smooth muscle of the mouse isolated vas deferens has been used to detect the packeted release of

59 lionic sympathetic axon bundles in mouse vas deferens have been characterized using confocal microsco

60 .6%) patients; unilateral absence of the vas deferens in 31 (11.2%) patients; obstructing cysts of th

61 uded congenital bilateral absence of the vas deferens in 94 (34.1%) patients; bilateral occlusion of

62 uctures (e.g., uterus in hermaphrodites, vas deferens in males).

63 l as congenital bilateral absence of the vas deferens in males.

64 e as the sperm transits to the cauda and vas deferens in preparation for its climactic release.

65 e CB1 and CB2 receptors and in the mouse vas deferens in vitro assay and the mouse tetrad in vivo ass

66 rrhosis), sweat glands (heat shock), and vas deferens (infertility).

67 o 80% of the net proton secretion in the vas deferens is inhibited by bafilomycin, consistent with a

68 al biliary cirrhosis, micro-gallbladder, vas deferens loss, airway disease, and meconium ileus.

69 devoid of agonist activity in the mouse vas deferens (MVD) and guinea pig ileum (GPI) preparations b

70 unctional activity in the mouse isolated vas deferens (MVD) and guinea pig isolated ileum (GPI) assay

71 in the guinea pig ileum (GPI) and mouse vas deferens (MVD) functional bioassays were determined for

72 on the guinea pig ileum (GPI) and mouse vas deferens (MVD) preparations.

73 in the guinea pig ileum (GPI) and mouse vas deferens (MVD) preparations.

74 s using guinea pig ileum (GPI) and mouse vas deferens (MVD) smooth muscle preparations.

75 the guinea pig ileum (GPI) and the mouse vas deferens (MVD) with EC50 values of 1.82 +/- 0.16 and 2.9

76 eurogenic contractions in the guinea pig vas deferens (n = 4-5).

77 h muscle was investigated in bladder and vas deferens of mice carrying a targeted mutation in both al

78 ostganglionic sympathetic neurons in the vas deferens of mice injected with IgG from LEMS patients or

79 the spicule-associated muscles pinch the vas deferens opening, thus blocking sperm release.

80 e to congenital bilateral absence of the vas deferens or nonclassic cystic fibrosis.

81 n-selective cation channels from the rat vas deferens (P2X1 receptors) were stably expressed in HEK 2

82 d; of these, one was cloned from the rat vas deferens (P2X1) and another from pheochromocytoma (PC12)

83 purines and noradrenaline (NA) from the vas deferens preparation differed from the pattern of overfl

84 f NA and the purines from the guniea-pig vas deferens preparation was examined after treatment with t

85 2-AR function was tested in two isolated vas deferens preparations.

86 uterine junction, and the development of vas deferens-proctodeal connection in the male.

87 nduced gene (FR-1) (80% identity), mouse vas deferens protein (MVDP) (76%), and human aldose reductas

88 evident within sympathetic fibers of the vas deferens, reflecting a high degree of spatial organizati

89 thetic nerves innervating the guinea-pig vas deferens releases not only neuronal ATP, but also solubl

90 Cultures from aorta, vas deferens, seminal vesicle, and kidney tissue were charac

91 1%) patients; bilateral occlusion of the vas deferens, seminal vesicles, and ejaculatory ducts by cal

92 g of the distal male reproductive tract (vas deferens, seminal vesicles, ejaculatory ducts).

93 onist exposure (0.5-4 hr) in the hamster vas deferens smooth muscle cell line (DDT1MF-2 cells).

94 resent on many excitable cells including vas deferens smooth muscle cells.

95 1 currents recorded from dissociated rat vas deferens smooth muscle cells.

96 Immunoelectron microscopy of vas deferens smooth muscle showed anti-RyR antibodies locali

97 e ryanodine receptor (RyR) in aortic and vas deferens smooth muscle was localized using immunofluores

98 peripheral and central SR in aortic and vas deferens smooth muscle.

99 versus 33.2% +/- 10.3% (P < 0.0001) for vas deferens sperm and 40.1% +/- 9.6% versus 33.2% +/- 7.5%

100 of the testis and associated structures (vas deferens, testicular vessels) and subsequent treatment o

101 itization than those found in the native vas deferens tissue, in agreement with previous reports.

102 ly reduced contraction of the guinea pig vas deferens to electrical field stimulation (EFS) and norep

103 eptor-deficient mice, contraction of the vas deferens to sympathetic nerve stimulation is reduced by

104 onent of the contractile response of the vas deferens to sympathetic nerve stimulation, which propels

105 Phasic SMCs (vas deferens, uterus and bladder) rely on membrane depolariz

106 rchitis), epididymis (epididymitis), and vas deferens (vasitis).

107 T1 in phasic rabbit portal vein (PV) and vas deferens (VD) smooth muscles.

108 rat aorta), and alpha(2A) (rat prostatic vas deferens) was also evaluated.

109 The bigenic ampullary glands and vas deferens were extremely cystic, hypertrophic and hyperpl

110 Smooth muscle cells in whole mouse deferens were loaded with the Ca(2+) indicator Oregon Gr

111 rminals and smooth muscle cells in mouse vas deferens were loaded with the Ca2+ indicator Oregon Gree

112 voked contractions of the mouse isolated vas deferens when administered at submicromolar concentratio

113 Superfusion of the vas deferens with exogenous epsilon-ATP, a fluorescent deriv

114 n P2X1 protein expression in Entpd1(-/-) vas deferens with no variation in mRNA levels.